OR WAIT null SECS
© 2023 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
MarkMonitor updates its surveillance surveys against counterfeiting and drug diversion
MarkMonitor, a ThomsonReuters company based in San Francisco, has had a business for many years of monitoring corporate brands as they appear online in discussion boards e-commerce or other forms of online transactions. Such brandname surveillance is a common activity of major consumer brand owners; for the pharma industry (MarkMonitor counts multiple multinational pharma companies among its clients). The guidance:
Illicit online activity in pharma is usually considered to be the sale of counterfeit drug, but there are important variations on that activity. Commercial sites trade in bulk supplies of finished products or APIs; drug diversion can range from product available in one channel (such as a specialty pharmacy) being available at unauthorized pharmacies. There have been sites that sell branded product at a “US” price and a lower “non-US” price (the latter is mostly illegal in the US, although FDA gives some latitude to individual patient purchasing). Another longstanding practice is “cybersquatting,” or the taking of a company brandname as a website address by another organization